CAPTRUST FINANCIAL ADVISORS - AEGLEA BIOTHERAPEUTICS INC ownership

AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 85 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of AEGLEA BIOTHERAPEUTICS INC
ValueSharesWeighting
Q1 2022$2,000
+100.0%
1,084
+533.9%
0.00%
Q4 2021$1,0001710.00%
Other shareholders
AEGLEA BIOTHERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Yu Fan 112,044$50,4200.68%
Aisling Capital Management LP 1,691,151$761,0180.50%
Sio Capital Management, LLC 3,004,959$1,351,9310.50%
Bain Capital Life Sciences Investors, LLC 5,347,689$2,4060.27%
Ghost Tree Capital, LLC 800,000$360,0000.15%
Nantahala Capital Management 4,611,302$2,074,6250.13%
Samsara BioCapital, LLC 883,720$397,5860.09%
SUVRETTA CAPITAL MANAGEMENT, LLC 4,059,894$1,826,5460.08%
SPHERA FUNDS MANAGEMENT LTD. 440,837$198,3330.04%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 245,678$1110.04%
View complete list of AEGLEA BIOTHERAPEUTICS INC shareholders